Firefly Neuroscience, Inc. (AIFF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Firefly Neuroscience, Inc. (AIFF) has a cash flow conversion efficiency ratio of -0.154x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.49 Million) by net assets ($9.66 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Firefly Neuroscience, Inc. market capitalisation for the company's overall valuation and market capitalisation.
Firefly Neuroscience, Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Firefly Neuroscience, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Firefly Neuroscience, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Firefly Neuroscience, Inc. ranked by their cash flow conversion efficiency. Explore earnings quality score of Firefly Neuroscience, Inc. to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Clearvue Technologies Ltd
AU:CPV
|
-0.405x |
|
CNPLUS Co. Ltd.
KQ:115530
|
0.851x |
|
Ateliers Mecaniques D’Indonesie Tbk PT
JK:AMIN
|
0.114x |
|
Cerenome, Inc.
NASDAQ:CNSY
|
-0.522x |
|
M4B SA ZY 8
F:24D
|
N/A |
|
Vital Metals Ltd
AU:VML
|
-0.022x |
|
Peruvian Metals Corp
V:PER
|
-0.152x |
|
Murray Cod Australia Ltd
AU:MCA
|
-0.066x |
Annual Cash Flow Conversion Efficiency for Firefly Neuroscience, Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of Firefly Neuroscience, Inc. from 2020 to 2024. View AIFF live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-375.00K | $-6.16 Million | 16.413x | +182.37% |
| 2023-12-31 | $109.00K | $-2.17 Million | -19.927x | -1554.53% |
| 2022-12-31 | $-2.11 Million | $-2.89 Million | 1.370x | +8.09% |
| 2021-12-31 | $-3.01 Million | $-3.82 Million | 1.267x | +383.11% |
| 2020-12-31 | $1.61 Million | $423.26K | 0.262x | -- |
About Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depres… Read more